/CBLL

Ceribell Inc

CBLL

$23.63USD↑+0.85%+0.20 today

MARKET CAP

906.9M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$23 – $24

52W RANGE

$11

$25

AI Summary

Stalk

Buy NowMedium

CBLL remains in a medium-term bullish Stage 2 advance, driven by an accelerating parabola structure. Price is holding just above the rising 9-day EMA after a shallow pullback, with EMAs stacked and momentum intact. RSI has eased from extreme overbought, suggesting room for consolidation or renewed upside. The path of least resistance remains higher, favoring entries near EMA support.

↑CBLL leads neurological diagnostics with digital health market tailwinds
↑1.62% dividend yield appeals to income-oriented investors
↓EPS fell short of estimates, causing a 0.8% share decline

Full analysis →

Buying

6

institutions

Selling

2

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	1.94 M	37.66 M	+122.94 K	+13.3%	0.00%
MM Millennium Management LLC Q2 2026	BUY	727.23 K	14.14 M	+175.20 K	+39.8%	0.01%
JC Jpmorgan Chase & Co Q2 2026	BUY	345.15 K	6.89 M	+57.95 K	+35.1%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	194.72 K	3.79 M	+-93.39 K	-28.3%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	BUY	96.25 K	1.87 M	+18.52 K	+31.4%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	95.66 K	1.86 M	+42.87 K	+92.3%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	52.32 K	1.02 M	+52.32 K	+0.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-14.20 K	-100.0%	0.00%